| fresh~horses 2005-12-10, 11:01 am |
| Serious errors in Vioxx study, medical journal says
Thursday, December 8, 2005 Posted at 10:31 PM EST
Canadian Press
Toronto - The New England Journal of Medicine publicly alleged
Thursday at least two of the authors of a major Canadian-led study on
the former blockbuster drug Vioxx withheld data on adverse events from
the journal.
In a stinging editorial released online, the prestigious journal did
not specify which of the study authors withheld the information.
But Dr. Gregory Curfman, executive editor of the journal, revealed in
an interview that the two were employees of Merck & Co., the company
which made the drug and funded the study.
-------snip------
http://www.theglobeandmail.com/serv...ienceandHealth/
~~~~~~~~~~~~~~~~~~~~
NEJM
Expression of Concern: Bombardier et al., "Comparison of Upper
Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients
with Rheumatoid Arthritis," N Engl J Med 2000;343:1520-8.
Gregory D. Curfman, M.D., Stephen Morrissey, Ph.D., and Jeffrey M.
Drazen, M.D.
http://content.nejm.org/cgi/reprint/NEJMe058314v1.pdf
|